Tak W. Mak, a Scientific Partner of Aravis, is the Director of the Campbell Family Institute of the Princess Margaret Hospital and a Professor of Immunology at the University of Toronto. He is best known for his discovery of the T-Cell receptor (1984), a key to the human immune system, and uses his knowledge for the creation and use of transgenic mice in Immunopathology and cancer.
Professor Mak is founder of Miikana Therapeutics, is a member of both the Scientific Advisory Boards of Kalypsys and Affibody, and was a member of the Lombard Odier Immunology Fund Scientific Advisory Board as well as being scientific advisor to a number of biotech and pharmaceutical companies.
Professor Mak has received numerous international awards including the Sloan Prize of the General Motors Cancer Foundation, Gairdner International Award, King Faisal International Prize for Medicine, Novartis Prize in Immunology, and the Paul Ehrlich Prize. He has also been elected a fellow of the Royal Society of London and a Foreign Associate of the US National Academy of Sciences.